COL4A3 and breast cancer: Cdh1, Col1a2, Col2a1, Col4a2, Col4a3, Col4a4, Col9a2, Nrxn1, Nrxn2 and Vegfb-related signaling pathways are decreased in BC (Fig. 6F).